💊 Sanofi's biotech investment fund grows bigger; The WHO red-flags India's Marion Biotech; A call for clean air

#253 | The WEF says climate change is a long term crisis

Hello, and welcome back to The Kable. We've got quite the packed edition for you today.

Brand new year, same old tale about the pharmacy of the world. Filings reveal that Sun Pharma, whose facility was already placed under an import alert by the US FDA last year, also received a warning letter last month for the same facility, calling Sun Pharma's response to a Form 483 from last year inadequate.

Elsewhere, the WHO issued a medical alert for two cough syrups manufactured by India's Marion Biotech that led to paediatric deaths in Uzbekistan. The agency says these syrups should not be used for children as lab analyses found the products contain unacceptable amounts of contaminants in the form of diethylene glycol and/or ethylene glycol.

In Uganda, the Sudan Ebolavirus outbreak is now officially over. While this is good news, it is disheartening that drugmakers around the world still remain unprepared for any other Sudan Ebolavirus outbreak anywhere.

Zimbabwe has been grappling with a healthcare staffing crisis on two fronts. Many nurses are migrating overseas, especially to the UK, while many nurses in the country have been protesting salaries and the working environment for a while. The government's solution? Send health workers to jail if they strike. Sure, that will resolve the staffing crisis.

And finally, more news on Ecuador's first human bird flu patient who presented with mild respiratory symptoms initially but had to be flown to the ICU later.